Navigation Links
CMC Biologics Announces Mark W. Sawicki as Vice President, Global Business Development
Date:9/10/2012

SEATTLE and COPENHAGEN, Denmark, Sept. 10, 2012 /PRNewswire/ -- CMC Biologics, a leading contract manufacturing organization known for its technical excellence in process development and cGMP manufacture, announced today it has hired Mark W. Sawicki, Ph.D., to serve as the Company's new Vice President of Global Business Development. Dr. Sawicki will be focused on business development, sales management, and the integration and alignment of the Company's global sales and marketing team.

(Logo:  http://photos.prnewswire.com/prnh/20110502/SF93356LOGO )

"Mark brings broad experience and documented success in the pharmaceutical/biotechnology industry," said Gustavo Mahler, Chief Operations Officer of CMC Biologics.  "His results-oriented approach and business acumen will play a pivotal role in extending our track record of innovation, while helping us grow profitability and take full advantage of the global contract manufacturing market opportunities ahead. In his role as Vice President, Global Business Development, he will be responsible for realizing the full potential of the sales and marketing team and provide leadership to this exciting phase of CMC Biologics' growth".

"CMC Biologics is very well respected, has a growing global customer base, offers world-class analytical, process development and manufacturing services, and has recently introduced new innovative services and technologies to its offering, giving the company a very attractive growth potential." said Dr. Sawicki. "I see a bright future for CMC Biologics and am eager to be part of the experienced and dedicated team and the challenges ahead."

Dr. Sawicki brings 10 years of business development and sales management experience, consistently delivering on corporate revenue and market share goals in the pharmaceutical/biotechnology industry.  Prior, Sawicki was Vice President, Business Development-Europe for Albany Molecular Research, Inc. responsible for business development and sales activity in the European theater, as well as global key account management strategy.  He consistently increased sales revenue at rates far outpacing industry standards from the EU Theater and prior, the US, and developed market analysis models for AMRI to determine market factors to proactively envisage future geographic/business shifts and trends. He holds Ph.D. and B.S. degrees in biochemistry from State University of New York at Buffalo; is a member of the Editorial Advisory of Pharmaceutical Outsourcing; and has more than a dozen publications in drug discovery and biochemistry.

About CMC Biologics

CMC Biologics is a global contract development and manufacturing organization that provides fully integrated biopharmaceutical development and manufacturing solutions to clients around the world from its facilities in Europe and the USA.  The Company has proven expertise in delivering custom solutions for the scale-up and cGMP manufacture of protein-based therapeutics for pre-clinical, clinical trials and commercial production.  The Company's wide range of integrated services includes cell line development, bioprocess development, formulation and comprehensive analytical testing.  Clients can also benefit from CMC Biologics' proprietary CHEF1® expression system for mammalian production.  CMC Biologics has fully segregated microbial fermentation and mammalian cell culture suites and offers both fed-batch and perfusion production processes.  CMC Biologics is located in Copenhagen, Denmark; Seattle, Washington; and Berkeley, California. More detailed information can be found at www.cmcbiologics.com.


'/>"/>
SOURCE CMC Biologics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
2. Synthetic Biologics Appoints Carol Reed, M.D., as Senior Vice President of Clinical & Regulatory Affairs
3. Avaxia Biologics is Awarded U.S. Patent for Method to Treat Radiation Damage to the Digestive Tract and Mucositis Caused by Radiation
4. CSL Behring Announces FDA Filing of Biologics License Application for 4-Factor PCC for Urgent Reversal of Vitamin K Antagonist Anticoagulant Therapy
5. Avaxia Biologics Announces Appointment of Michael D. Rivard as VP Corporate Development
6. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
7. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
8. Pinnacle Biologics and INTERmedic Medical Devices announce strategic manufacturing and distribution agreement for cancer laser technology
9. CMC Biologics Acquires XOMAs Bay Area Manufacturing Facility
10. Global Spinal Devices and Biologics Market 2011-2015
11. Synthetic Biologics Reports Second Quarter 2012 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)...  Arkis BioSciences, a leading innovator in the ... cerebrospinal fluid treatments, today announced it has secured ... led by Innova Memphis, followed by Angel Capital ... Arkis, new financing will accelerate the commercialization of ... of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... , June 23, 2016 Any dentist who has ... of the current process. Many of them do not even ... technical difficulties and high laboratory costs involved. And those who ... it at such a high cost that the majority of ... Dr. Parsa Zadeh , founder of Dental Evolutions ...
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: RO, ... clearance for its Elecsys BRAHMS PCT (procalcitonin) assay as ... or septic shock. With this clearance, Roche is the ... fully integrated solution for sepsis risk assessment and management. ... bacterial infection and PCT levels in blood can aid ...
Breaking Medicine Technology:
(Date:6/27/2016)... ... June 27, 2016 , ... TopConsumerReviews.com recently awarded their highest five-star ... , Millions of individuals in the United States and Canada wear eyeglasses. Once considered ... both correct vision and make a fashion statement. Even celebrities use glasses as a ...
(Date:6/26/2016)... (PRWEB) , ... June 26, 2016 , ... Brent Kasmer, a legally blind and certified ... be personalized through a fitness app. The fitness app plans to fix the two major ... only offer a one size fits all type program , They don’t eliminate ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... June 25, 2016 , ... Conventional wisdom preaches the benefits of moderation, ... the latter, setting the bar too high can result in disappointment, perhaps even self-loathing. ... toward their goal. , Research from PsychTests.com reveals that behind the ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):